Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
68.10
+1.16 (1.73%)
At close: Feb 6, 2026, 4:00 PM EST
68.03
-0.07 (-0.10%)
After-hours: Feb 6, 2026, 4:20 PM EST
Arcellx Market Cap
Arcellx has a market cap or net worth of $3.94 billion as of February 6, 2026. Its market cap has increased by 10.59% in one year.
Market Cap
3.94B
Enterprise Value
3.42B
1-Year Change
10.59%
Ranking
Category
Stock Price
$68.10
Market Cap Chart
Since the IPO on February 4, 2022, Arcellx's market cap has increased from $503.15M to $3.94B, an increase of 682.61%. That is a compound annual growth rate of 67.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 3.87B | 2.67% |
| Dec 31, 2025 | 3.77B | -9.09% |
| Dec 31, 2024 | 4.15B | 43.89% |
| Dec 29, 2023 | 2.88B | 112.13% |
| Dec 30, 2022 | 1.36B | 170.02% |
| Feb 4, 2022 | 503.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apogee Therapeutics | 4.38B |
| TG Therapeutics | 4.26B |
| Corcept Therapeutics | 4.22B |
| CG Oncology | 4.19B |
| ACADIA Pharmaceuticals | 4.10B |
| ADMA Biologics | 3.92B |
| Terns Pharmaceuticals | 3.92B |
| Ligand Pharmaceuticals | 3.90B |